Discover
GH
Guardant Health, Inc.
167.47
2 x 155.09
2 x 180.42
bid
ask
+
1.91
1.15%
2 @ 04:03 PM
167.40 -0.07 (0.04%)
| Ytd | 63.96% | |
| 1y | 156.62% |
166.03
day range
170.81
61.73
52 week range
187.22
| Open | 166.85 | Prev Close | 165.56 | Low | 166.03 | High | 170.81 | Mkt Cap | 22.47B |
| Vol | 1.52M | Avg Vol | 1.98M | EPS | -3.54 | P/E | N/A | Forward P/E | -400.71 |
| Beta | 1.58 | Short Ratio | 5.70 | Inst. Own | 100.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 167.56 | 200-d Avg | 125.42 | 1yr Est | 200.44 |
| Income Statement | |||
| Total Revenue | 334.98M | ||
| Revenues (USD) | 334.98M | ||
| Cost of Revenue | 115.95M | ||
| Gross Profit | 219.03M | ||
| Operating Expenses | 348.15M | ||
| Research and Development Expense | 96.53M | ||
| Selling, General and Administrative Expense | 251.61M | ||
| Operating Income | -129.12M | ||
| Interest Expense | 1.35M | ||
| Income Tax Expense | 185.00K | ||
| Net Income | -120.14M | ||
| Net Income Common Stock | -120.14M | ||
| Net Income Common Stock (USD) | -120.14M | ||
| Consolidated Income | -120.14M | ||
| Earnings per Basic Share | -0.90 | ||
| Earnings per Basic Share (USD) | -0.90 | ||
| Earnings per Diluted Share | -0.90 | ||
| Earning Before Interest & Taxes (EBIT) | -118.61M | ||
| Earning Before Interest & Taxes (USD) | -118.61M | ||
| Weighted Average Shares | 132.87M | ||
| Weighted Average Shares Diluted | 132.87M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.17B | ||
| Cash and Equivalents (USD) | 1.17B | ||
| Trade and Non-Trade Receivables | 144.25M | ||
| Current Assets | 1.36B | ||
| Property, Plant & Equipment Net | 302.87M | ||
| Total Assets | 1.91B | ||
| Total Debt | 1.67B | ||
| Current Liabilities | 338.96M | ||
| Debt Non-Current | 1.67B | ||
| Total Liabilities | 2.14B | ||
| Accumulated Retained Earnings (Deficit) | -3.23B | ||
| Accumulated Other Comprehensive Income | -5.56M | ||
| Shareholders Equity | -222.87M | ||
| Shareholders Equity (USD) | -222.87M | ||
| Assets Non-Current | 547.66M | ||
| Total Debt (USD) | 1.67B | ||
| Deferred Revenue | 44.79M | ||
| Goodwill and Intangible Assets | 102.52M | ||
| Inventory | 105.46M | ||
| Liabilities Non-Current | 1.80B | ||
| Trade and Non-Trade Payables | 93.51M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 9.56M | ||
| Net Cash Flow from Financing | 23.01M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 66.30M | ||
| Capital Expenditure | -11.76M | ||
| Issuance (Purchase) of Equity Shares | 28.29M | ||
| Net Cash Flow from Investing | 101.47M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 113.23M | ||
| Net Cash Flow from Operations | -57.78M | ||
| Effect of Exchange Rate Changes on Cash | -411.00K | ||
| Share Based Compensation | 57.73M | ||